OTTR Q1 2026 Earnings Earnings Beat Drives Positive Sentiment Despite Modest Stock Dip Tenaya Therapeutics Q1 2026 Earnings Narrow Miss on Earnings as Biotech Firm Reports No Revenue PDD Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Declines SPRY Q1 2026 Earnings EPS Miss and Continued Cash Burn Amid Pipeline Development CAC Q1 2026 Earnings EPS Beats Estimates by Nearly 3 Amid Modest Stock Decline GRDX Q1 2026 Earnings PreRevenue Stage with Widening Losses